BGB-290-103

Completed

Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors

Beigene Study ID info

BGB-290-103

ClinicalTrials.gov ID info

EudraCT Number info

2017-001553-14

Study Overview

Sex: All

Age: 18 Years / 99 Years

No Study Documents

Study Overview

Sex: All

Age: 18 Years / 99 Years

No Study Documents